National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 15441-15442 [2022-05775]
Download as PDF
<![CDATA[
15441
Federal Register / Vol. 87, No. 53 / Friday, March 18, 2022 / Notices
Public Comments’’ or by using the
search function.
To
request a copy of the clearance requests
submitted to OMB for review, email
Samantha Miller, the acting HRSA
Information Collection Clearance Officer
at paperwork@hrsa.gov or call (301)
443–9094.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Rural Health Clinic COVID–19 (RHC
COVID–19) Reporting Portal, OMB No.
0906–0056—Revision.
Abstract: In October 2020, HRSA’s
Federal Office of Rural Health Policy
(FORHP) created a monthly, aggregate
data report to collect information on
COVID–19 testing and related expenses
conducted by funded organizations
participating in the RHC COVID–19
Testing (RHCCT) Program funded
through the Paycheck Protection
Program and Health Care Enhancement
Act (Pub. L. 116–139). FORHP is
expanding this data report to collect
information on COVID–19 testing,
COVID–19 mitigation, and related
expenses conducted by funded
organizations participating in the RHC
COVID–19 Testing and Mitigation
(RHCCTM) Program funded through the
American Rescue Plan Act (Pub. L. 117–
2). Funded organizations were
identified by Tax Identification Number
(TIN), and a TIN organization may
operate one or more RHC sites which
were identified by unique CMS
Certification Numbers. Respondents are
TIN organizations who received funding
for COVID–19 testing, COVID–19
mitigation, and related expenses. HRSA
issued RHCCTM funding as one-time
FOR FURTHER INFORMATION CONTACT:
payments to 2,301 TIN organizations
based on the number of certified RHC
sites they operate, providing $100,000
per clinic site (4,459 RHC sites total
across the country). Data report
information is needed to comply with
federal requirements to monitor funds
distributed under the Paycheck
Protection Program and Health Care
Enhancement Act and the American
Rescue Plan Act.
A 60-day notice published in the
Federal Register, 87 FR 103 (January 3,
2022). There were no public comments.
Need and Proposed Use of the
Information: The RHC COVID–19
Reporting Portal collects information
from RHC-funded providers who use
RHCCT Program funding and RHCCTM
Program funding to support COVID–19
testing, expand access to testing in rural
communities, and other related
expenses. The RHC COVID–19
Reporting Portal also collects
information from RHC-funded providers
who use RHCCTM Program funding to
support COVID–19 mitigation and other
related expenses. These data are critical
to meet FORHP’s requirements to
monitor and report on how federal
funding is being used and to measure
the effectiveness of the RHCCT Program
and RHCCTM Program. Revisions
include a confirmation page for TIN
organization self-certification following
completion of each program after the
period of availability. Specifically, these
data will be used to assess the
following:
• Whether program funds are being
spent for their intended purposes;
• COVID–19 testing or testing related
use(s) of RHCCTM funds;
• COVID–19 mitigation or mitigation
related use(s) of RHCCTM funds;
• Where COVID–19 testing supported
by these funds is occurring;
• Number of at-home (i.e., home
collection; direct-to-consumer; over-thecounter) COVID–19 tests distributed
(optional);
• Number of COVID–19 tests;
• Number of positive COVID–19 tests;
• TIN organizations self-certification
of complete expenditure of RHCCT
Program funds and/or full or partial
return of RHCCT Program funds; and
• TIN organizations self-certification
of complete expenditure of RHCCTM
Program funds and/or full or partial
return of RHCCTM Program funds.
Likely Respondents: Respondents are
TIN organizations who own or operate
one or more RHC who received funding
for COVID–19 testing, COVID–19
mitigation, and related expenses.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
jspears on DSK121TN23PROD with NOTICES1
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
RHC COVID–19 Reporting Portal .......................................
2,301
19
43,719
0.33
14,427
Total ..............................................................................
2,301
........................
43,719
........................
14,427
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
VerDate Sep<11>2014
18:27 Mar 17, 2022
Jkt 256001
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Maria G. Button,
Director, Executive Secretariat.
National Institutes of Health
[FR Doc. 2022–05719 Filed 3–17–22; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
Frm 00084
Fmt 4703
Sfmt 4703
E:\FR\FM\18MRN1.SGM
18MRN1
15442
Federal Register / Vol. 87, No. 53 / Friday, March 18, 2022 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials and
Biomarker Studies in Stroke.
Date: April 11, 2022.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Boulevard,
Suite 3208, MSC 9529, Bethesda, MD 20892,
301–435–6033, rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: March 15, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05775 Filed 3–17–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jspears on DSK121TN23PROD with NOTICES1
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
18:27 Mar 17, 2022
Jkt 256001
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity PAR review.
Date: April 19, 2022.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIDDK/National Institutes of Health,
6707 Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353,
6707 Democracy Boulevard, Bethesda, MD
20892–2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05772 Filed 3–17–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; Exploratory/Developmental
Research Grant Program Review Panel.
Date: April 8, 2022.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 6700B Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
6700 B Rockledge Drive, Room 2114,
Bethesda, MD 20892, (301) 451–2067,
srinivar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: March 14, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05726 Filed 3–17–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Deciphering Immune-CNS Interactions in
HIV (R01, R21).
Date: April 14, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Room 6149, MSC 9608, Bethesda, MD 20892–
9608, 301–443–4525, steinerr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 87, Number 53 (Friday, March 18, 2022)]
[Notices]
[Pages 15441-15442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05775]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
[[Page 15442]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Clinical Trials and Biomarker
Studies in Stroke.
Date: April 11, 2022.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive Boulevard, Suite 3208,
MSC 9529, Bethesda, MD 20892, 301-435-6033, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: March 15, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-05775 Filed 3-17-22; 8:45 am]
BILLING CODE 4140-01-P
